CSPC Pharmaceutical Group (HK:1093) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
CSPC Pharmaceutical Group has renewed lease agreements with CHL and NCP for three years starting January 2025, involving industrial premises in Shijiazhuang, China for drug production. These agreements are categorized as connected transactions under Hong Kong’s Listing Rules, requiring reporting and announcement but exempt from independent shareholder approval. The move indicates CSPC’s strategic alignment with its substantial shareholder’s associates to continue its production activities.
For further insights into HK:1093 stock, check out TipRanks’ Stock Analysis page.
